ArticleScientific reports2019

Caveolin-1 gene therapy inhibits inflammasome activation to protect from bleomycin-induced pulmonary fibrosis.

Xin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.